How do I compare QSC and WWB on lead time to Finland?

Setup, so nobody has to ask: QSC · WWB · Finland.

I suspect the honest answer is that it depends, in which case I would like to know on what.

Assume I can obtain either option without difficulty, so availability is not the deciding factor.

Under what conditions does the answer flip?

The honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

Compare content, not purity. Purity clusters and content does not.

The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

The part that matters: publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

The caveat is that a comparison is a snapshot of the lots compared, and lots change.

Price per milligram of measured peptide, not per milligram of label claim.

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Use a fixed documentation checklist rather than an impression.

This is the question where methodology matters more than the conclusion.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

One laboratory, one method, one submission. Otherwise it is not a comparison.

edited 20 Feb 2025 by low_dead_space — updated for the 2026 guidance change

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Name the laboratory and the dates or the comparison cannot be reproduced.

edited 22 Dec 2024 by g_paskevicius — removed a claim I could not source